Milk-derived bioactive peptides: From science to applications

Journal of Functional Foods

Volumn 1, Issue 2, 2009, Pages 177-187

  Korhonen, Hannu ^a  

^a FINNISH FOREST RESEARCH INSTITUTE   (Finland)

Author keywords

Applications; Bioactive peptides; Functionality; Milk proteins; Production

Indexed keywords

EID: 64549156088     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2009.01.007     Document Type: Article

References (103)

1. Aihara K., Kajimoto O., Hirata H., Takahashi R., and Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of American College of Nutrition 4 (2005) 257-265
2. Ashar M.N., and Chand R. Fermented milk containing ACE-inhibitory peptides reduces blood pressure in middle aged hypertensive subjects. Milchwissenschaft 59 (2004) 363-366
3. Ardö Y., Lilbaek H., Kristiansen K.R., Zakora M., and Otte J. Identification of large phosphopeptides from β-casein that characteristically accumulate during ripening of the semi-hard cheese Herrgård. International Dairy Journal 17 (2007) 513-524
4. Bütikofer U., Meyer J., Sieber R., and Wechsler D. Quantification of the angiotensin-converting enzyme-inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheeses. International Dairy Journal 17 (2007) 968-975
5. Chen G.-W., Tsai J.-S., and Sun Pan B. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. International Dairy Journal 17 (2007) 641-647
6. Chobert J.-M., El-Zahar K., Sitohy M., Dalgalarrondo M., Métro F., Choiset Y., and Haertle T. Angiotensin I-converting-enzyme (ACE) inhibitory activity of tryptic peptides of ovine β-lactoglobulin and of milk yoghurts obtained by using different starters. Lait 85 (2005) 141-152
7. deCosta E.L., Rocha Montijo J.A., and Netto F.M. Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. International Dairy Journal 17 (2007) 632-640
8. Clare D.A., and Swaisgood H.E. Bioactive milk peptides: A prospectus. Journal of Dairy Science 83 (2000) 1187-1195
9. Donkor O., Henriksson A., Vasiljevic T., and Shah N.P. Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of growth and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 86 (2007) 21-38
10. Erdman K., Cheung B.W.Y., and Schröder H. The possible role of food-derived bioactive peptides in reducing the risk of cardiovascular disease. Journal of Nutritional Biochemistry 19 (2008) 643-654
11. Engberink M.F., Schouten E.G., Kok F.J., van Mierlo L.A., Brouwer I.A., and Geleijnse J.M. Lactotripeptides show no effect on human blood pressure: Results from a double-blind randomized controlled trial. Hypertension 51 (2008) 399-405
12. Ferreira I.M.P.L.V.O., Pinho O., Mota M.V., Tavares P., Pereira A., Goncalves M.P., Torres D., Rocha C., and Teixeira J.A. Preparation of ingredients containing an ACE-inhibitory peptide by tryptic hydrolysis of whey protein concentrates. International Dairy Journal 17 (2007) 481-487
13. FitzGerald R.J., and Meisel H. Milk protein hydrolysates and bioactive peptides. Advanced dairy chemistry. 3rd ed. In: Fox P.F., and McSweeney P.L.H. (Eds). Proteins Vol. 1 (2003), Kluwer Academic/Plenum Publishers, New York 675-698
14. FitzGerald R.J., Murray B.A., and Walsh D.J. Hypotensive peptides from milk proteins. Journal of Nutrition 134 (2004) 980S-988S
15. FitzGerald R.J., and Murray B.A. Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 59 (2006) 118-125
16. Foltz M., Meynen E.E., Bianco V., van Platerink C., Koning T.M., and Klock J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide - Enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition 137 (2007) 953-958
17. Fuglsang A., Rattray F.P., Nilsson D., and Nyborg N.C.B. Lactic acid bacteria: Inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie van Leeuwenhoek 83 (2003) 27-34
18. Gauthier S.F., Pouliot Y., and Saint-Sauveur D. Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal 16 (2006) 1315-1323
19. Gagnaire V., Molle D., Herrouin M., and Leonil J. Peptides identified during Emmental cheese ripening: Origin and proteolytic systems involved. Journal of Agricultural and Food Chemistry 49 (2001) 4402-4413
20. Gobbetti M., Minervini F., and Rizzello C.G. Angiotensin I-converting-enzyme-inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology 57 (2004) 172-188
21. Gobbetti M., Stepaniak L., De Angelis M., Corsetti A., and Di Cagno R. Latent bioactive peptides in milk proteins: Proteolytic activation and significance in dairy processing. Critical Reviews in Food Science and Nutrition 42 (2002) 223-239
22. Gobbetti M., Minervini F., and Rizzello C.G. Bioactive peptides in dairy products. In: Hui Y.H. (Ed). Handbook of food products manufacturing (2007), John Wiley and Sons, Inc., Hoboken, New Jersey 489-517
23. Gomez-Ruiz J.A., Ramos M., and Recio I. Angiotensin-converting enzyme-inhibitory peptides in Manchego cheeses manufactured with different starter cultures. International Dairy Journal 12 (2002) 697-706
24. Haque E., and Chand R. Antihypertensive and antimicrobial bioactive peptides from milk proteins. European Food Research and Technology 227 (2008) 7-15
25. Hartmann R., and Meisel H. Food-derived peptides with biological activity: From research to food applications. Current Opinion in Biotechnology 18 (2007) 1-7
26. Hata Y., Yamamoto M., Ohni H., Nakajima K., Nakamura Y., and Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. American Journal of Clinical Nutrition 64 (1996) 767-771
27. Hernández-Ledesma B., Amigo L., Ramos M., and Recio I. Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 52 (2004) 1504-1510
28. Hernández-Ledesma B., Amigo L., Ramos M., and Recio I. Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. International Dairy Journal 14 (2004) 889-898
29. Hernández-Ledesma B., Quiros A., Amigo L., and Recio I. Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. International Dairy Journal 17 (2007) 42-49
30. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S., Nakamura Y., and Kitakaze M. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertension Research 30 (2007) 489-496
31. Jauhiainen T., and Korpela R. Milk peptides and blood pressure. Journal of Nutrition 137 (2007) 825S-829S
32. Jauhiainen T., Vapaatalo H., Poussa T., Kyrönpalo S., Rasmussen M., and Korpela R. Lactobacillus helveticus fermented milk reduces blood pressure in 24-h ambulatory blood pressure measurement. American Journal of Hypertension 18 (2005) 1600-1605
33. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., and Korpela R. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. International Dairy Journal 17 (2007) 1216-1223
34. Jauhiainen T., Rönnback M., Vapaatalo H., Wuolle K., Kautiainen H., and Korpela R. Lactobacillus helveticus fermented milk reduces arterial stiffness in hypertensive subjects. International Dairy Journal 17 (2007) 1209-1211
35. Kilara A., and Panyam D. Peptides from milk proteins and their properties. Critical Reviews in Food Science and Nutrition 43 (2003) 607-633
36. Kilpi E.E.-R., Kahala M.M., Steele J.L., Pihlanto A.M., and Joutsjoki V.V. Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. International Dairy Journal 17 (2007) 976-984
37. s1-casein expressed in Escherichia coli. Journal of Dairy Research 66 (1999) 431-439
38. Kitts D.D., and Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9 (2003) 1309-1323
39. Korhonen H. Technology options for new nutritional concepts. International Journal of Dairy Technology 55 (2002) 79-88
40. Korhonen H., and Pihlanto A. Food-derived bioactive peptides - Opportunities for designing future foods. Current Pharmaceutical Design 9 (2003) 1297-1308
41. Korhonen H., and Pihlanto A. Bioactive peptides: Production and functionality. International Dairy Journal 16 (2006) 945-960
42. Korhonen H., and Pihlanto A. Bioactive peptides from food proteins. In: Hui Y.H. (Ed). Handbook of food products manufacturing (2007), John Wiley and Sons Inc., Hoboken, New Jersey 5-37
43. Korhonen H., and Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Current Pharmaceutical Design 13 (2007) 829-843
44. Lee Y.-M., Skurk T., Hennig M., and Hauner H. Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension. European Journal of Nutrition 46 (2007) 21-27
45. Li G., Le G., Shi Y., and Shrestha S. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24 (2004) 469-486
46. López-Fandino R., Otte J., and Van Camp J. Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 16 (2006) 1277-1293
47. López-Expósito I., Quiros A., Amigo L., and Recio I. Casein hydrolysates as a source of antimicrobial, antioxydant and antihypertensive peptides. Lait 87 (2007) 241-249
48. López-Expósito I., and Recio I. Antibacterial activity of peptides and folding variants from milk proteins. International Dairy Journal 16 (2006) 1294-1305
49. López-Expósito I., and Recio I. Protective effect of milk peptides: Antibacterial and antitumor properties. In: Bösze Z. (Ed). Advances in experimental medicine and biology: Bioactive components of milk Vol. 606 (2008), Springer, Newyork, USA 271-294
50. Lorenzen P.C., and Meisel H. Influence of trypsin action in yoghurt milk on the release of caseinophosphopeptide-rich fractions and physical properties of the fermented products. International Journal of Dairy Technology 58 (2005) 119-124
51. Maes W., van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers J.M., Schrezenmeier J., van Oostveldt P., and Huyghebaert A. Influence of the lactokinin Ala-Leu-Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regulatory Peptides 118 (2004) 105-109
52. Manso M.A., and López-Fandino R. κ-Casein macropeptides from cheese whey: Physicochemical, biological, nutritional, and technological features for possible uses. Food Reviews International 20 (2004) 329-355
53. Masuda O., Nakamura Y., and Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. Journal of Nutrition 126 (1996) 3063-3068
54. Matar C., LeBlanc J.G., Martin L., and Perdigón G. Biologically active peptides released in fermented milk: Role and functions. In: Farnworth E.R. (Ed). Handbook of fermented functional foods. Functional foods and nutraceuticals series (2003), CRC Press, Florida 177-201
55. McDonagh D., and FitzGerald R.J. Production of caseinophosphopeptides (CPPs) from sodium caseinate using a range of commercial protease preparations. International Dairy Journal 8 (1998) 39-45
56. Meisel H. Biochemical properties of peptides encrypted in bovine milk proteins. Current Medicinal Chemistry 12 (2005) 1905-1919
57. Meisel H., and FitzGerald R.J. Biofunctional peptides from milk proteins: Mineral binding and cytomodulatory effects. Current Pharmaceutical Design 9 (2003) 1289-1295
58. Meisel H., Goepfert A., and Günther S. ACE-inhibitory activities in milk products. Milchwissenschaft 52 (1997) 307-311
59. Meisel H., Walsh D.J., Murray B., and FitzGerald R.J. ACE inhibitory peptides. In: Mine Y., and Shahidi F. (Eds). Nutraceutical proteins and peptides in health and disease. Nutraceutical science and technology Vol. 4 (2006), Taylor and Francis, Boca Raton, FL 269-315
60. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., Kajimoto Y., and Yamamoto N. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high normal blood pressure and mild hypertension. British Journal of Nutrition 94 (2005) 84-91
61. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., Tochikubo O., and Ueshima H. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. American Journal of Hypertension 17 (2004) 701-706
62. Muehlenkamp M.R., and Warthesen J.J. β-Casomorphins: Analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp. cremoris. Journal of Dairy Science 79 (1996) 20-26
63. Mullally M.M., Meisel H., and FitzGerald R.J. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Letters 402 (1997) 99-101
64. Murray B.A., and FitzGerald R.J. Angiotensin converting enzyme inhibitory peptides derived from food proteins: Biochemistry, bioactivity and production. Current Pharmaceutical Design 13 (2007) 773-791
65. Möller N.P., Scholz-Ahrens K.E., Roos N., and Schrezenmeir J. Bioactive peptides and proteins from foods: Indication for health effects. European Journal of Nutrition 47 (2008) 171-182
66. Nakamura Y., Yamamoto N., Sakai K., and Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of Dairy Science 78 (1995) 1253-1257
67. O'Donnell R., Holland J.W., Deeth H.C., and Alewood P. Milk proteomics. International Dairy Journal 14 (2004) 1013-1023
68. Ong L., Henriksson A., and Shah N.P. Angiotensin converting enzyme-inhibitory activity in Cheddar cheeses made with the addition of probiotic Lactobacillus casei sp. Lait 87 (2007) 149-165
69. Otte J., Shalaby S.M., Zakora M., Pripp A.H., and El-Shabrawy S.A. Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: Effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 17 (2007) 488-503
70. Quiros A., Hernandez-Ledesma B., Ramos M., Amigo L., and Recio I. Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. Journal of Dairy Science 88 (2005) 3480-3487
71. Quiros A., Ramos M., Muguerza B., Delgado M., Miguel M., Alexaindre A., and Recio I. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 17 (2007) 33-41
72. Packard R.R.S., and Libby P. Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 54 (2008) 24-38
73. Pan D., Luo Y., and Tanokura M. Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food Chemistry 91 (2004) 123-129
74. Parrot S., Degraeve P., Curia C., and Martial-Gros A. In vitro study on digestion of peptides in Emmental cheese: Analytical evaluation and influence on angiotensin I converting enzyme inhibitory peptides. Nahrung 47 (2003) 87-94
75. Pihlanto A. Antioxidative peptides derived from milk proteins. International Dairy Journal 16 (2006) 1306-1314
76. Pihlanto A., and Korhonen H. Bioactive peptides and proteins. In: Taylor S.L. (Ed). Advances in food and nutrition research Vol. 47 (2003), Elsevier Inc., San Diego, USA 175-276
77. Pihlanto-Leppälä A., Koskinen P., Piilola K., Tupasela T., and Korhonen H. Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. Journal of Dairy Research 67 (2000) 53-64
78. Pihlanto-Leppälä A., Rokka T., and Korhonen H. Angiotensin I-converting enzyme inhibitory peptides derived from bovine milk proteins. International Dairy Journal 8 (1998) 325-331
79. Pins J.J., and Keenan J.M. Effects of whey peptides on cardiovascular disease risk factors. Journal of Clinical Hypertension 8 (2006) 775-782
80. Pouliot Y., Gauthier S.F., and Groleau P.E. Membrane-based fractionation and purification strategies for bioactive peptides. In: Mine Y., and Shahidi F. (Eds). Nutraceutical proteins and peptides in health and disease nutraceutical science and technology Vol. 4 (2006), Taylor and Francis, Boca Raton, FL 639-658
81. Reynolds E.C. Dairy components in oral health. Australian Journal of Dairy Technology 58 (2003) 79-81
82. Rokka T., Syväoja E.-L., Tuominen J., and Korhonen H. Release of bioactive peptides by enzymatic proteolysis of Lactobacillus GG fermented UHT-milk. Milchwissenschaft 52 (1997) 675-678
83. Roudot-Algaron F., LeBars D., Kerhoas L., Einhorn J., and Gripon J.C. Phosphopeptides from Comté cheese: Nature and origin. Journal of Food Science 59 (1994) 544-547
84. Roufik S., Gauthier S.F., and Turgeon S.L. In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. International Dairy Journal 16 (2006) 294-302
85. Ryhänen E.-L., Pihlanto-Leppälä A., and Pahkala E. A new type of ripened: Low-fat cheese with bioactive properties. International Dairy Journal 11 (2001) 441-447
86. Sabikhi L., and Mathur B.N. Qualitative and quantitative analysis of β-casomorphins in Edam cheese. Milchwissenschaft 56 (2001) 198-200
87. Saito T., Nakamura T., Kitazawa H., Kawai Y., and Itoh T. Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. Journal of Dairy Science 83 (2000) 1434-1440
88. Saito T. Antihypertensive peptides derived from bovine casein and whey proteins. In: Bösze Z. (Ed). Advances in experimental medicine and biology: Bioactive components of milk Vol. 606 (2008), Springer, Newyork, USA 295-317
89. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., Nakagawa S., Kajimoto Y., and Nakamura Y. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. Journal of Medicinal Food 8 (2005) 423-430
90. Seppo L., Jauhiainen T., Poussa T., and Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 77 (2003) 326-330
91. Seppo L., Kerojoki O., Suomalainen T., and Korpela R. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension - A pilot study on humans. Milchwissenschaft 57 (2002) 124-127
92. Silva S.V., and Malcata F.X. Caseins as source of bioactive peptides. International Dairy Journal 15 (2005) 1-15
93. Singh T.K., Fox P.F., and Healy A. Isolation and identification of further peptides in the diafiltration retentate of the water-soluble fraction of Cheddar cheese. Journal of Dairy Research 64 (1997) 433-443
94. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., and Nurminen M.-L. Effect of long-term intake of milk products on blood pressure in hypertensive rats. Journal of Dairy Research 69 (2002) 103-111
95. Smacchi E., and Gobbetti M. Peptides from several Italian cheeses inhibitory to proteolytic enzymes of lactic acid bacteria: Pseudomonas fluorescens ATCC 948 and to the angiotensin I-converting enzyme. Enzyme Microbiology and Technology 22 (1998) 687-694
96. Takano T. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leeuwenhoek 82 (2002) 333-340
97. Teschemacher H. Opioid receptor ligands derived from food proteins. Current Pharmaceutical Design 9 (2003) 1331-1344
98. Townsend R.R., McFadden C.B., Ford V., and Cadee J.A. A randomized, double-blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. American Journal of Hypertension 17 (2004) 1056-1058
99. Tuomilehto J., Lindström J., Hyyrynen J., Korpela R., Karhunen M.-L., Mikkola L., Jauhiainen T., Seppo L., and Nissinen A. Effect of ingesting sour milk fermented by Lactobacillus helveticus bacteria on blood pressure in subjects with mild hypertension. Journal of Human Hypertension 18 (2004) 795-802
100. Vermeirssen V., van Camp J., and Verstraete W. Bioavailability of angiotensin I-converting enzyme inhibitory peptides. British Journal of Nutrition 92 (2004) 357-366
101. Virtanen T., Pihlanto A., Akkanen S., and Korhonen H. Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. Journal of Applied Microbiology 102 (2006) 106-115
102. Zimecki M., and Kruzel M.L. Milk-derived proteins and peptides of potential therapeutic and nutritive value. Journal of Experimental Therapy and Oncology 6 (2007) 89-106
103. Yamamoto N., Ejiri M., and Mizuno S. Biogenic peptides and their potential use. Current Pharmaceutical Design 9 (2003) 1345-1355